PMC:7346000 / 14293-14871 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T43","span":{"begin":226,"end":231},"obj":"Body_part"},{"id":"T44","span":{"begin":393,"end":398},"obj":"Body_part"},{"id":"T45","span":{"begin":484,"end":488},"obj":"Body_part"}],"attributes":[{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A44","pred":"fma_id","subj":"T44","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A45","pred":"fma_id","subj":"T45","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T10","span":{"begin":226,"end":231},"obj":"Body_part"},{"id":"T11","span":{"begin":393,"end":398},"obj":"Body_part"},{"id":"T12","span":{"begin":484,"end":488},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"415","span":{"begin":59,"end":67},"obj":"Species"},{"id":"416","span":{"begin":549,"end":557},"obj":"Species"},{"id":"417","span":{"begin":50,"end":58},"obj":"Disease"},{"id":"418","span":{"begin":138,"end":150},"obj":"Disease"},{"id":"419","span":{"begin":165,"end":173},"obj":"Disease"},{"id":"420","span":{"begin":187,"end":194},"obj":"Disease"},{"id":"421","span":{"begin":208,"end":212},"obj":"Disease"},{"id":"422","span":{"begin":226,"end":240},"obj":"Disease"},{"id":"423","span":{"begin":254,"end":274},"obj":"Disease"},{"id":"424","span":{"begin":292,"end":298},"obj":"Disease"},{"id":"425","span":{"begin":370,"end":382},"obj":"Disease"},{"id":"426","span":{"begin":393,"end":407},"obj":"Disease"},{"id":"427","span":{"begin":413,"end":421},"obj":"Disease"},{"id":"428","span":{"begin":443,"end":452},"obj":"Disease"},{"id":"429","span":{"begin":484,"end":495},"obj":"Disease"},{"id":"430","span":{"begin":506,"end":510},"obj":"Disease"},{"id":"431","span":{"begin":514,"end":520},"obj":"Disease"}],"attributes":[{"id":"A415","pred":"tao:has_database_id","subj":"415","obj":"Tax:9606"},{"id":"A416","pred":"tao:has_database_id","subj":"416","obj":"Tax:9606"},{"id":"A417","pred":"tao:has_database_id","subj":"417","obj":"MESH:C000657245"},{"id":"A418","pred":"tao:has_database_id","subj":"418","obj":"MESH:D006973"},{"id":"A419","pred":"tao:has_database_id","subj":"419","obj":"MESH:D003920"},{"id":"A420","pred":"tao:has_database_id","subj":"420","obj":"MESH:D009765"},{"id":"A421","pred":"tao:has_database_id","subj":"421","obj":"MESH:D029424"},{"id":"A422","pred":"tao:has_database_id","subj":"422","obj":"MESH:D006331"},{"id":"A424","pred":"tao:has_database_id","subj":"424","obj":"MESH:D001249"},{"id":"A425","pred":"tao:has_database_id","subj":"425","obj":"MESH:D006973"},{"id":"A426","pred":"tao:has_database_id","subj":"426","obj":"MESH:D006331"},{"id":"A427","pred":"tao:has_database_id","subj":"427","obj":"MESH:D003920"},{"id":"A428","pred":"tao:has_database_id","subj":"428","obj":"MESH:D007239"},{"id":"A429","pred":"tao:has_database_id","subj":"429","obj":"MESH:D008171"},{"id":"A430","pred":"tao:has_database_id","subj":"430","obj":"MESH:D029424"},{"id":"A431","pred":"tao:has_database_id","subj":"431","obj":"MESH:D001249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T146","span":{"begin":50,"end":58},"obj":"Disease"},{"id":"T147","span":{"begin":79,"end":83},"obj":"Disease"},{"id":"T148","span":{"begin":98,"end":102},"obj":"Disease"},{"id":"T149","span":{"begin":138,"end":150},"obj":"Disease"},{"id":"T150","span":{"begin":165,"end":173},"obj":"Disease"},{"id":"T151","span":{"begin":187,"end":194},"obj":"Disease"},{"id":"T152","span":{"begin":208,"end":212},"obj":"Disease"},{"id":"T153","span":{"begin":226,"end":240},"obj":"Disease"},{"id":"T154","span":{"begin":292,"end":298},"obj":"Disease"},{"id":"T155","span":{"begin":370,"end":382},"obj":"Disease"},{"id":"T156","span":{"begin":384,"end":407},"obj":"Disease"},{"id":"T157","span":{"begin":413,"end":421},"obj":"Disease"},{"id":"T158","span":{"begin":443,"end":452},"obj":"Disease"},{"id":"T159","span":{"begin":506,"end":510},"obj":"Disease"},{"id":"T160","span":{"begin":514,"end":520},"obj":"Disease"}],"attributes":[{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A150","pred":"mondo_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A151","pred":"mondo_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/MONDO_0011122"},{"id":"A152","pred":"mondo_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A153","pred":"mondo_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"},{"id":"A154","pred":"mondo_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A155","pred":"mondo_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A156","pred":"mondo_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A157","pred":"mondo_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A158","pred":"mondo_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A159","pred":"mondo_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A160","pred":"mondo_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T104","span":{"begin":95,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T105","span":{"begin":155,"end":157},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T106","span":{"begin":177,"end":179},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T107","span":{"begin":198,"end":200},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T108","span":{"begin":216,"end":218},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T109","span":{"begin":226,"end":231},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T110","span":{"begin":226,"end":231},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T111","span":{"begin":226,"end":231},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T112","span":{"begin":226,"end":231},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T113","span":{"begin":244,"end":246},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T114","span":{"begin":278,"end":280},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T115","span":{"begin":282,"end":284},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T116","span":{"begin":302,"end":304},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T117","span":{"begin":393,"end":398},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T118","span":{"begin":393,"end":398},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T119","span":{"begin":393,"end":398},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T120","span":{"begin":393,"end":398},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T121","span":{"begin":484,"end":488},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T122","span":{"begin":484,"end":488},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T86","span":{"begin":569,"end":572},"obj":"Chemical"}],"attributes":[{"id":"A86","pred":"chebi_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A87","pred":"chebi_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T36","span":{"begin":138,"end":150},"obj":"Phenotype"},{"id":"T37","span":{"begin":187,"end":194},"obj":"Phenotype"},{"id":"T38","span":{"begin":208,"end":212},"obj":"Phenotype"},{"id":"T39","span":{"begin":292,"end":298},"obj":"Phenotype"},{"id":"T40","span":{"begin":370,"end":382},"obj":"Phenotype"},{"id":"T41","span":{"begin":506,"end":510},"obj":"Phenotype"},{"id":"T42","span":{"begin":514,"end":520},"obj":"Phenotype"},{"id":"T43","span":{"begin":569,"end":572},"obj":"Phenotype"}],"attributes":[{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0001513"},{"id":"A38","pred":"hp_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"id":"A40","pred":"hp_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A41","pred":"hp_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A42","pred":"hp_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/HP_0002099"},{"id":"A43","pred":"hp_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/HP_0020103"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T73","span":{"begin":0,"end":84},"obj":"Sentence"},{"id":"T74","span":{"begin":85,"end":363},"obj":"Sentence"},{"id":"T75","span":{"begin":364,"end":578},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}

{"project":"2_test","denotations":[{"id":"32599813-30104296-60095115","span":{"begin":462,"end":464},"obj":"30104296"},{"id":"32599813-9259669-60095116","span":{"begin":465,"end":467},"obj":"9259669"},{"id":"32599813-30879371-60095117","span":{"begin":468,"end":470},"obj":"30879371"},{"id":"32599813-15882191-60095118","span":{"begin":574,"end":576},"obj":"15882191"}],"text":"Underlying medical conditions may also predispose COVID-19 patients to develop CAPA. Among the 35 CAPA cases published to date (Table 1), hypertension (17/35; 49%), diabetes (9/35; 26%), obesity (8/35; 23%), COPD (5/35; 14%), heart diseases (5/35; 14%), hypercholesterinemia (4/35; 11%), and asthma (3/35; 9%) were among the most prevalent comorbidities observed. While hypertension, coronary heart diseases, and diabetes increase the risk of infection overall [67,68,69], structural lung damage caused by COPD or asthma may particularly predispose patients to develop IPA [70]."}